Immunoreactivity in granular cell tumours of the larynx

Auris Nasus Larynx

Volumn 26, Issue 3, 1999, Pages 305-310

  Lassaletta, Luis ^a   Alonso, Soledad ^a   Ballestín, Claudio ^a   Martínez Tello, Francisco José ^a   Álvarez Vicent, Juan José ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Granular cell tumor; Immunohistochemistry; Laryngeal neoplasms; p53 expression

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CASE REPORT; DYSPHAGIA; FEMALE; GRANULAR CELL; GRANULAR CELL TUMOR; HOARSENESS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARYNX TUMOR; MALE; PROGNOSIS; PROTEIN EXPRESSION; SCHWANN CELL; TUMOR LOCALIZATION;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRANULAR CELL TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LARYNX; MALE; MIDDLE AGED; SCHWANN CELLS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032967220     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0385-8146(98)00069-8     Document Type: Article

References (25)

1. Filie A.C., Lage J.M., Azumi N. Immunoreactivity of S100 protein alpha-1-antitrypsin and CD68 in adult and congenital GCTs. Mod Pathol. 9:1996;888-892.
2. LeBoit P.E., Barr R.J., Burall S., Metcalf J.S., Yen T.S., Wick M.R. Primitive polypoid granular-cell tumour and other cutaneous granular-cell neoplasms of apparent nonneural origin. Am J Surg Pathol. 15:1991;48-58.
3. Regezi J.A., Zarbo R.J., Courtney R.M., Crissman J.D. Immunoreactivity of granular cell lesions of skin mucosa and jaw. Cancer. 64:1989;1455-1460.
4. Rickert C.H., Kuchelmeister K., Gullotta F. Morphological and immunohistochemical characterisation of granular cells in non-hypophyseal tumours of the central nervous system. Histopathology. 30:1997;464-471.
5. Lassaletta L, Alonso S, Villafruela MA, Martinez-Tello FJ, Alvarez-Vicent JJ. Tumor de células granulares: una causa poco frecuente de disfonía en la infancia. Acta Otorrinolaringol Esp, in press.
6. Compagno J., Hyams V.J., Ste-Marie P. Benign granular cell tumours of the larynx: a review of 36 cases with clinicopathologic data. Ann Otol Rhinol Laryngol. 84:1975;308-314.
7. Hamid A.M., Alshaikhly A. Granular cell tumour of the larynx in an 8-year-old girl. J Laryngol Otol. 107:1993;940-941.
8. Torsiglieri A.J. Jr., Handler S.D., Uri A.K. Granular cell tumours of the head and neck in children: the experience at the Children's Hospital of Philadelphia. Int J Pediatr Otorhinolaryngol. 21:1991;249-258.
9. Shapiro A.M., Rimell F.L., Kenna M.A. Pathologic quiz case 1 Granular cell tumour GCT of larynx. Arch Otolaryngol Head Neck Surg. 121:1995;1058-1061.
10. Enzinger F.M., Weiss S.W. Soft Tissue Tumours. 3rd edn:1994;864-875 Mosby, St Louis.
11. Kershisnik M., Batsakis J.G., Mackay B. Granular cell tumours. Ann Otol Rhinol Laryngol. 103:1994;416-419.
12. Cree I.A., Bingham B.J., Ramesar K.C. Granular cell tumour of the larynx. J Laryngol Otol. 104:1990;159-161.
13. Buley I.D., Gatter K.C., Kelly P.M., Heryet A., Millard P.R. Granular cell tumours revisited. An immunohistological and ultrastructural study. Histopathology. 12:1988;263-274.
14. Ogawa K., Oguchi M., Yamabe H., Nakashima Y., Hamashima Y. Distribution of collagen type IV in soft tissue tumours. An immunohistochemical study. Cancer. 58:1986;269-277.
15. Ferlito A. Surgical Pathology of Laryngeal Neoplasms. 1995;253 Chapman and Hall, London.
16. Zidar N., Gale N., Cor A., Kambic V. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. J Laryngol Otol. 110:1996;440-445.
17. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
18. Chang F., Syrjanen S., Syrjanen K. Implications of the p53 tumour-suppressor gene in clinical oncology [see comments]. J Clin Oncol. 13:1995;1009-1022.
19. Maestro R., Dolcetti R., Gasparotto D. et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene. 7:1992;1159-1166.
20. Spafford M.F., Koeppe J., Pan Z., Archer P.G., Meyers A.D., Franklin W.A. Correlation of tumour markers p53 bcl-2 CD34 CD44H CD44v6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 122:1996;627-632.
21. Watling D.L., Gown A.M., Coltrera M.D. Overexpression of p53 in head and neck cancer. Head Neck. 14:1992;437-444.
22. Ingle R.R., Setzen G., Koltai P.J., Monte D., Pastore J., Jennings T.A. p53 protein expression in benign lesions of the upper respiratory tract. Arch Otolaryngol Head Neck Surg. 123:1997;297-300.
23. Thomas de Montpreville V., Dulmet E.M. Granular cell tumours of the lower respiratory tract. Histopathology. 27:1995;257-262.
24. Hall P.A. Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! [editorial]. J Pathol. 172:1994;1-4.
25. Munck Wikland E., Edstrom S., Jungmark E., Kuylenstierna R., Lindholm J., Auer G. Nuclear DNA content proliferating-cell nuclear antigen PCNA and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int J Cancer. 56:1994;95-99.